November 9, 2009 By:April Lewis
Stopping the madness behind the current methods in enrollment planning.
 |
November 1, 2009 By:Josip Aralica
As a part of Europe, but not the European Union, trials in Croatia can encounter special challenges
 |
November 1, 2009
Changing current business models with the use of new advancements for more sustainability.
 |
November 1, 2009 By:Kenneth A. Getz
Economic factors and sponsor practices will dramatically alter the investigative site landscape.
 |
November 1, 2009 By:Karen Politis Virk
Economical development and regulatory standards make the country a logical choice for trials.
 |
November 1, 2009
How Italy's new quality-driven regulations will ask more of CROs conducting activities in the country.
 |
October 22, 2009 By:Marissa Shapiro
Why knowing a drug's risk and preparing for a risk evaluation mitigation strategy early on will considerably benefit a drug's development.
 |
|